top of page

Welcome to SANGUINE


Project SANGUINE is dedicated to improving cancer care by developing a groundbreaking blood test for hematological malignancies. These types of cancer affect thousands of people in Europe each year. The test, using innovative technology, detects specific biomarkers in the blood, enabling early detection and better patient outcomes. SANGUINE brings together a team of experts in medicine, technology, and patient advocacy to ensure the test is effective, accessible, and affordable. By providing validated tools and software, the project aims to revolutionize cancer screening and make a positive impact on the lives of patients and their loved ones across Europe.

About Us

SANGUINE is a pioneering project developing a cutting-edge blood test for early detection of hematological malignancies

SANGUINE is an innovative project at the forefront of cancer research, focused on advancing the field of hematological malignancies by developing a state-of-the-art blood test that enables early detection of these cancers, leading to improved treatment outcomes and enhanced quality of life for patients.

DALL·E 2024-02-06 00_edited.jpg

Contact Us

Get in touch with us for any inquiries or collaborations regarding the SANGUINE project.

Empowering Early Detection, Transforming Lives

bottom of page